Blue Trust’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Blue Trust's IBB Position: Q3 2026 in Review
Blue Trust increased its iShares Biotechnology ETF (IBB) stake by 5.7% in Q3 2026, buying an estimated $11.2K and bringing the position to 1,037 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #724.
Blue Trust first reported a position in IBB in Q2 2022 and has held it in 18 quarters since. 920 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Blue Trust held 1,037 shares of iShares Biotechnology ETF worth $218K as of Q3 2026.
- Blue Trust bought 56 iShares Biotechnology ETF shares in Q3 2026, an estimated $11.2K.
- iShares Biotechnology ETF made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #724 holding.
- Blue Trust first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 18 quarters since.
- 920 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.